$CPRX News Article - Catalyst Pharmaceuticals to L
Post# of 79
(Total Views: 206)
Posted On: 06/20/2023 1:30:50 PM
$CPRX News Article - Catalyst Pharmaceuticals to License North American Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals https://marketwirenews.com/news-releases/cata...27301.html
(0)
(0)Catalyst Pharmaceuticals Inc. (CPRX) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼